stockrow
Monday 2 November 2026
Export CLX’s income statement to Excel — free account
The Clorox Company
CLX Consumer Defensive Household & Personal Products
The Clorox Company’s revenue for fiscal 2026 (year ended June 2026) was $6.7 billion, down 5.41% from fiscal 2025.
- Revenue
- +33.3%
- EPS
- +113.9%
- Free cash flow
- +11.4%
- Total debt
- +60.2%
Quarter to September 2026, against a year earlier
90.05
2.05
+2.33%
Follow CLX
Alert me
| Sep '26 From the 10-Q filed 2 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
3 | 4 | 6 | 5 |
+8 more TTM periods Free account |
| 522.78% | 159.95% | 536.17% | 967.95% | ||
| 10.13% | 8.79% | 12.65% | 13.49% | ||
ROIC |
0.00% | 13.95% | 48.49% | 28.17% | |
Return on Tangible Assets |
147.49% | 104.26% | 103.42% | 120.22% | |
Average Days of Receivables |
37.79 | 42.96 | 36.23 | 36.24 | |
Free Cash Flow per Share |
3.72 | 3.33 | 3.13 | 6.40 | |
Free Cash Flow |
453.00 | 405.00 | 380.00 | 778.00 | |
Capital Expenditures |
(209.00) | (207.00) | (196.00) | (206.00) | |
| Other line items | |||||
Cash ROIC |
10.57% | 9.25% | 10.09% | 28.31% | |
Accounts Receivable Turnover |
9.94 | 8.34 | 10.66 | 10.61 | |
Accounts Payable Turnover |
2.31 | 2.26 | 2.17 | 2.21 | |
Inventory Turnover |
6.19 | 5.96 | 6.21 | 6.29 | |
Average Days of Payables |
147.56 | 150.67 | 142.21 | 189.37 | |
Days of Inventory on Hand |
67.62 | 73.17 | 56.54 | 58.83 | |
Tax Rate |
(0.22) | (0.24) | (0.22) | (0.22) | |
Research and Development Expense of Revenue |
1.63% | 1.73% | 1.72% | 1.72% | |
Selling, General and Administrative Expense of Revenue |
25.74% | 27.01% | 26.15% | 27.17% | |
Share Based Compensation of Revenue |
0.65% | 0.71% | 0.98% | 1.11% | |
Interest Coverage |
0.00 | 7.02 | 11.13 | 11.12 | |
Operating CF/Net income |
0.98 | 1.04 | 0.76 | 1.30 | |
Depreciation/Fixed assets |
0.18 | 0.16 | 0.18 | 0.18 | |
Capex/Depreciation |
(0.79) | (0.84) | (0.87) | (0.92) | |
Revenue per Share |
59.17 | 55.18 | 55.70 | 55.57 | |
Operating CF per Share |
5.44 | 5.03 | 4.75 | 8.09 | |
Capex per Share |
(1.72) | (1.70) | (1.61) | (1.69) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 |
Columns are period end dates · fundamentals updated 2 Nov 2026